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Sequence controlled multi-block glycopolymers to inhibit DC-SIGN-gp120 
binding** 
Qiang Zhang, Jennifer Collins, Athina Anastasaki, Russell Wallis, Daniel A. Mitchell, C. Remzi 
Becer and David M. Haddleton* 
Glycan-protein interactions are essential for many physiological 
processes including cell-cell recognition, cell adhesion, cell 
signalling, pathogen identification and differentiation. Dendritic 
cell-specific intercellular adhesion molecule-3-grabbing non-
integrin (DC-SIGN; CD209) is a C-type lectin (carbohydrate-
binding protein) present on both macrophages and dendritic cell 
subpopulations and play a critical role in many cell interactions. 
DC-SIGN binds to microorganisms and host molecules by 
recognizing surface rich mannose containing glycans through 
multivalent glycan-protein interactions and serves a target for 
several viruses such as human immunodeficiency virus (HIV) and 
hepatitis C virus (HCV).[1]  Carbohydrate binding proteins (CBP) 
have been suggested as potential candidate microbiocides for the 
prevention of HIV infection.[2] However, the isolation of natural 
CBPs is relatively difficult due to their hydrophilic nature and they 
show notably low affinities to virus.[3],[4] and thus synthetic lectins 
are of interest for carbohydrate recognition studies.[5] Alternatively, 
non-carbohydrate inhibitors of mammalian lectins can be used to 
prevent the interaction between DC-SIGN and gp120.[6] The 
architectures of the multivalent ligands have a great effect on 
carbohydrate binding to lectins and the use of linear polymers on 
effective lectin binding has been demonstrated by several research 
groups.[7] 
Synthetic polymer chemistry has developed rapidly in recent 
years.[8] Currently, polymerization of functional monomers with 
desired chain length, architecture and composition is straightforward 
whereas polymers with any monomer sequence control structures 
remains challenging[9][10] which have implications for the controlled 
folding of synthetic macromolecules.[11] There are a few recent 
reports where sufficient control has been achieved in controlling the 
monomer sequence along the polymer chain.[12] To the best of our 
knowledge this is the first report where some control over the 
relative position of sugars is exhibited with a demonstration of their 
binding to the human lectin DC-SIGN. We have utilized a 
controlled polymerization technique, single electron transfer living 
radical polymerization (SET-LRP)[13][14][15][12c], to polymerize 
glycomonomers reaction prior to polymerization.  
A series of glycomonomers were prepared by reaction of 3-
azidopropylacrylate (APA) and alkylated mannose, glucose and 
fucose, via Fischer-Helferich glycosylation. This was performed 
using CuSO4 and sodium ascorbate in methanol/water mixture (see 
supporting information). SET-LRP of glucose monomer (GluA) was 
performed in dimethylsulfoxide (DMSO) using a Cu(0)/Cu(II) and 
Me6TREN derived catalyst. Polymerization reached over 90% 
monomer conversion in 6 hours whilst maintaining a narrow 
molecular weight distribution with increasing molecular weight. 
(ESI, Fig. S4) The obtained polymers were characterized by size 
exclusion chromatography (SEC) and matrix assisted laser 
desorption ionization time of flight mass spectroscopy (MALDI-
ToF MS) or high-resolution electrospray ionization mass 
spectroscopy (HR-ESI MS) that indicated very high chain end 
fidelity allowing for sequential monomer addition.  
We designed a polymerization reaction starting with 1 
equivalent of initiator and 2 equivalents of mannose glycomonomer 
(ManA), (Fig 1a). ManA was fully consumed after 12 hours, 2 
equivalents of GluA in DMSO were added to the reaction mixture 
and GluA was consumed in 16 hours and 2 equivalents of ManA in 
DMSO was subsequently injected into the reaction mixture. This 
cycle was continued until six short blocks of glycopolymers was 
achieved (DP=2 for each block, (mannose)2-(glucose)2-(mannose)2-
(glucose)2-(mannose)2-(glucose)2). No purification steps were 
required prior to subsequent addition of the subsequent monomer. 
The conversion of the first four blocks, 1H NMR analysis, reached 
100% evidenced by complete disappearance of vinyl groups, 5.7 to 
6.5 ppm. The glycomonomers were dissolved in purged DMSO 
prior to the addition and this resulted in further dilution of the 
reaction medium for each monomer addition. Traces of vinyl groups 
could still be detected after the fifth (conv: 99%) and sixth (conv: 
97%) blocks. Moreover, the reaction was followed by SEC and, 
especially for the short chain length, the resolution of the columns 
allowed identification of the molecules with one, two and three 
repeating units as would be expected for a controlled polymerisation 
reaction.  
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Figure 1. Sequence controlled mannose-glucose hexa block 
copolymer. a, Schematic representation of the sequence controlled 
multi block copolymerization of ManA and GluA. b, SEC traces of the 
glycopolymers prior to each addition of glycomonomer. c,HR-ESI MS 
of the first poly(Man)2 and second block poly(Man)2-s-(Glu)2. 
The hydrodynamic volume of the polymers increased with every 
monomer addition and polydispersity indices (PDI) remained low 
(Fig 1b). A more detailed structural characterization was performed 
using HR-ESI MS and most of the formed molecules could be 
identified (Fig 1c). 
Similar reaction conditions were employed for the preparation 
of a polymer with longer block lengths. The average degree of 
polymerization was increased to 4 and the reaction time was kept > 
20h for each step to ensure the full monomer conversion. The 
molecular weight of the first block (poly(Man)4) =4.7 kDa with a 
PDI =1.11 and after addition of 4 eq. GluA the molecular weight of 
the polymer (poly(Man)4-s-(Glu)4) was increased to 7.7 kDa with a 
PDI = 1.08. However, after the third (4 eq. of Man) and fourth (4 eq. 
of Glu) glycomonomer additions, the PDI of the polymers increased 
to 1.22 and 1.37, respectively, which indicate some loss of control 
and a reduction in chain end fidelity. (Fig.S10) The chain end 
fidelity was probed by transformation of the bromide to azide and 
performing CuAAC with propargyl dibromomaleimide. SEC 
equipped with both RI and UV detectors (λ = 400 nm) demonstrated 
a high chain end fidelity for the hexablock polymer (FigS20).  
This approach was extended further by the introduction of a 
third, and different glycomonomer, fucose acrylate (FucA) and 
prepared a hexablock copolymer of ManA, GluA and FucA. (ESI, 
Fig S11) Molecular weights of the obtained glycopolymers 
increased as expected and PDI values remained <1.13 throughout 
the reaction. This allows for the synthesis of synthetic glycans that 
may form the basis of an extensive synthetic glycocode.[16] 
Stimuli-responsive materials attract attention, as this allows for 
solubility changes upon corresponding changes in the surrounding 
environment. It should also be noted that the distance between sugar 
units can have a critical importance for lectin binding. Therefore, we 
developed a thermo-responsive mannose carrying sequence 
controlled multi-block copolymer. (Fig. 2) SET-LRP of di(ethylene 
glycol) ethyl ether acrylate (DEGEEA) was initiated with a 
[monomer]/[initiator] ratio of 6 and the monomer conversion 
reached over 90% in 2.5 h, S4. In the subsequent step, 3 equivalents 
of ManA were added and more than 90% of this monomer was 
consumed in 4.5 h and the cycle continued until the polymer reached 
a hexablock structure. SEC traces (Fig 2b) showed an increased 
molecular weight where the PDI values stayed <1.28 throughout the 
reaction. More detailed structural characterization was performed 
utilizing MALDI-ToF MS (Fig 2c) and all species could be 
identified. These examples show a level of sequence control 
obtained in one pot, relatively large scale, using cheap starting 
materials, and with the minimum work up at the end polymerization. 
Interactions between the glycopolymers and DC-SIGN were 
measured using surface plasmon resonance spectroscopy. ManMA58 
was used as a control for binding (Fig 3a).[17] All glycopolymers and 
gp120 (analytes) were measured at 6-10 different concentrations and 
a representative spectrum is shown in Figure 3c. The blue zones are 
the ones where buffer was flowed over the chip alonebefore (90 sec) 
and after (650 sec) injection of the analyte (900 s). Association (kon) 
and dissociation rate constants (koff) were calculated using a 2-
ligand binding model using Biacore evaluation software, and KD 
values were calculated from the ratio of koff to kon, (Table 1) HIV 
gp120 showed the highest affinity for DC-SIGN (0.11 nM). All of 
the glycopolymers bound to DC-SIGN with affinities ranging 
between 0.6 and 34 nM. Typically, polymers with a higher mannose 
content bound with higher affinities reflecting the known preference 
of DC-SIGN for mannose over glucose. Incorporation of fucose 
restored a degree of high affinity binding.[18] 
It is noted that the koff values were low and approaching lower limit 
for surface plasmon resonance measurements.  
Competition experiments were performed by flowing 4 nM of 
DC-SIGN in buffer with varying amounts of glycopolymers over 
immobilized gp120. In the representative SPR sensogram (Fig 3d) 
the highest Rmax is observed, as expected, when DC-SIGN is passed 
over gp120 in the absence of glycopolymer, thus representing 
maximal binding. DC-SIGN binding decreases upon addition of 
more glycopolymer as carbohydrate moieties of the polymer block 
binding sites on the lectin (ESI, Fig S33). The lowest IC50 value 
observed was for solution-phase gp120 (11 nM).  Nevertheless, 
impressive inhibition was also observed for ManMA58, ManA23 and 
ManA13-b-OEGA2, only 10-30-fold weaker than for gp120. S3, S5 
and S6 showed little inhibition over the measured concentration 
range. Favourable binding of ManA23 over ManMA58, despite its 
shorter chain length may reflect differences in acrylic and 
methacrylic polymer backbones and also the linker structure, which 
could lead to different behaviour in chain folding and lectin binding 
(ESI, Fig S33).  
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Figure 2. Sequence controlled DEGEEA-mannose hexa block 
copolymer. a, Schematic representation of the sequence controlled 
multi block copolymerization of DEGEEA and ManA. b, SEC traces of 
the glycopolymers before each addition of monomer. c, MALDI-ToF 
MS of the second block poly(DEGEEA)6-s-(Man)3. 
Table 1.The results of binding kinetics and inhibition concentration of 
glycopolymers. 
  DC-SIGN binding  
Code Sequence kon 
(M-1s-1) 
koff 
(s-1)a 
KD 
(nM)b 
IC50 
(nM) 
gp120 gp120 7.3×105 7.8×10-5 0.11 11 
C1 ManMA58 2.9×105 2.0 ×10-4 0.66 230 
S1 ManA23 8.0×104 3.1×10-5 0.39 153 
S2 ManA13-b-OEGA2 3.6×104 7.6×10-5 2.2 380 
S3 ManA9-r-DEGEEA18 3.9×103 2.6×10-5 6.6 >1000 
S4 ManA9-s-DEGEEA18 4.7×103 6.7×10-5 14 >1000 
S5 GluA6-s-ManA4-s-FucA4 4.0×103 6.2×10-5 15 >1000 
S6 GluA4-s-ManA4-s-GluA4 9.7×103 9.7×10-5 34 n/a 
[a] koff values are close to the limit of the SPR technique, so probably 
reflect upper limits. [b] For the same reason in [a] above, KD values 
probably also represent upper limits. -b-, -r-, and -s- stand for block, 
random, and sequence controlled, respectively. 
This supports that inhibition of binding of DC-SIGN to gp120 is 
via blocking carbohydrate-binding sites on the lectin.  Notably, 
however, KD and IC50 values were different for each polymer.  For 
example, KD and IC50 values of ManA13-b-OEGA2 were 2.18 nM 
and 380 nM, respectively.  These differences reflect the complex, 
multivalent nature of the interactions between polymer and DC-
SIGN as well as between gp120 and DC-SIGN.    Binding is shown 
to be dependent on both the sequence and structure of the polymer 
highlighting the potential importance of this synthetic strategy. 
 
 
 
 
Figure 3. 
Glycopolymer- DC-SIGN 
binding and competition assays.Top, typical SPR sensograms 
showing the DC-SIGN glycopolymer S1 interaction at different 
concentrations.Bottom,dark green trace with the highest intensity 
belongs to DC-SIGN binding to gp120 in the absence of any 
glycopolymer and the lower ones belong to competitive binding in the 
presence glycopolymer S1 at different concentrations. 
In conclusion, we have prepared multi-block glycopolymers 
with a degree of monomer sequence controlled in various 
compositions from glycomonomers containing mannose, glucose 
and fucose moieties. Polymerizations were followed by 1H NMR, 
SEC and HR ESI-MS or MALDI-ToF MS to obtain information on 
the products. This technique gives a good degree of control over the 
monomer sequence along a polymer chain. The polymerization is 
performed in one pot by sequential addition of the subsequent 
monomers in a relatively a large scale. The obtained glycopolymers 
were examined for their binding behaviour to DC-SIGN. We 
observed higher affinity binding for the polymers with higher 
mannose content. However, we could not conclude any effect of 
sequence on binding in this system, most likely because DC-SIGN 
preferentially recognises a range of high-mannose structures whilst 
other DC-SIGN binding glycans of mixed monosaccharide character 
possess very defined glycosidic branching.[18b] Further work will be 
performed using lectin libraries and sequence controlled polymer 
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libraries to evaluate the sugar sequence or distance and their impact 
on specific lectin binding properties, in addition to the 
polymerization of small disaccharide and oligosaccharide units such 
as Man--(1,2)-Man and blood group antigens. Nevertheless, the 
synthesized polymers reported here show distinct binding properties 
to DC-SIGN and an inhibition of the DC-SIGN binding to HIV 
gp120 using nano molar concentrations. 
  
Syntheses of all materials and details of characterisation methods are 
provided in the supporting information.  
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